Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Molecule
Products 31 to 38 of 38
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
SmartDNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:00 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
SmokeCloak DNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/02/04 14:40 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
Spear-T Liquid Concentrate
by
Venter Institute
+
Vestaron
Biotech components:
Gene Editing
+
Molecule
+
Yeast
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/17 11:00 (5 years ago)
Date last modified:
2019/09/17 11:00 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
+
Plant
Production process:
N/A
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Finished Product
Succinic Acid
by
Myriant
+
Royal DSM
+
BioAmber, Inc.
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:37 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
SYN-005
by
Synthetic Biologics
+
Intrexon
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:27 (6 years ago)
Known funding amount:
24,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
Synthorin™ Protein
by
Synthorx
+
Scripps Research Institute
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
79,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
TALEN
by
Cellectis
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
+
France
Country of distribution:
USA
+
France
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
17,400,000 EUR
Funding types:
Shareholder Investment
Industry:
Health
+
Multipurpose
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CLLS, ALCLS
(NASDAQ, EPA)
Value chain stage:
Platform
Unique DNA Signatures as a Security System for Homes
by
SelectaDNA
Biotech components:
Molecule
Business models:
B2C
Country of production:
UK
Country of distribution:
UK
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Security
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
